Epilepsy, one of the most frequent neurological diseases, is defined by the International League Against Epilepsy (ILAE) as “the enduring predisposition to suffer epileptic seizures” (Fisher et al., 2014).
The burden of epilepsy remains a public health issue worldwide, particularly in developing countries, where 90% of people with epilepsy (PWE) live. These subjects are often misdiagnosed or left untreated, due to economical or educational deficiencies.
Drug resistance is found in 30% of PWE. This condition is associated with significant medical and psychiatric comorbidities, thus affecting the patient's social, family and work environment.
Mike Cisneros-Franco
Postdoctoral fellow
Doing research at the intersection of Neuroscience and Economics
Publications
Self-reported Quality of Life in Pharmacoresistant Temporal Lobe Epilepsy; Correlation With Clinical Variables and Memory Evaluation
Objective testing revealed specific memory deficits that were not reflected in self-reported Quality of Life scores
Impact of the implementation of the AAN epilepsy quality measures on the medical records in a university hospital
A simple intervention led to a better practice standardization and documentation for diagnostic and counseling purposes
